8 results match your criteria: "Bar-Ilan Medical School[Affiliation]"

The within-subject variability (WSV) of pain-intensity reports has gained attention as a predictor of the placebo response but has demonstrated mixed results. We hypothesized that participants' inward- and outward-directed attention will moderate WSV's prediction of the analgesic placebo response. In this sham randomized clinical trial (protocol number NCT05994118); placebo response was induced in chronic back-pain patients (n=113) through a saline injection plus verbal suggestion.

View Article and Find Full Text PDF

Autoimmune myelofibrosis (AIMF) is an uncommon cause of myelofibrosis associated with favorable outcome. Primary AIMF, AIMF without a known systemic autoimmune disorder, has been described in adults, but never in children. Here, we present, for the first time, an apparent case of primary AIMF in a 15-year-old boy admitted with profound hypoproliferative anemia.

View Article and Find Full Text PDF

Background: Pyogenic spondylodiscitis is diagnosed in recent years at higher rates due to the aging population, increased survival of chronic and immune suppressed patients, and the higher rate of invasive procedures leading to bacterial seeding or direct contamination of the disc space. Treatment guidelines encourage bacterial sampling before initiation of antibiotic therapy, and drainage of pus collections. We present our experience with percutaneous CT-guided drain insertion into the disc space itself as a one-step procedure for both culturing and subsequent continuous drainage of the infected disc space.

View Article and Find Full Text PDF

Adolescent injuries and fatalities constitute a world health concern and present a major public health burden. Of all childhood injuries in Israel 61.8% occur during road traffic crashes.

View Article and Find Full Text PDF

Use of the Combined First-Trimester Screen in High- and Low-Risk Patient Populations After Introduction of Noninvasive Prenatal Testing.

J Ultrasound Med

August 2015

Division of Maternal-Fetal Medicine, Eastern Virginia Medical School, Norfolk, Virginia USA (S.L., S.L.W., L.R., M.M., A.Z.A.); and Department of Obstetrics and Gynecology, Ziv Medical Center, Bar-Ilan Medical School, Zefat, Israel (D.P.).

Objectives: To report changes in the use of the combined first-trimester screen (FTS) in patients classified as high and low risk for fetal aneuploidy, including after introduction of noninvasive prenatal testing (NIPT).

Methods: A prospectively collected database was reviewed to investigate changes in FTS use before and after American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin No. 77 (Obstet Gynecol 2007; 109:217-227), which recommended that all patients be offered aneuploidy screening, and after NIPT introduction.

View Article and Find Full Text PDF

The impact of Ramadan fast on patients with gout.

J Clin Rheumatol

October 2014

From the *Department of Medicine, Carmel Medical Center; and †Faculty of Medicine, Technion, Israel Institute of Technology, Haifa; and ‡Rheumatology Clinic, Nazareth Hospital, Nazareth; §Department of Neurology, ║Department of Medicine, Carmel Medical Center, and ¶Department of Orthopedics, Carmel Medical Center, Haifa; #Diet Unit, Carmel Medical Center; and Departments of **Orthopedics and ††Radiology, Nazareth Hospital, Nazareth, Bar-Ilan Medical School, Tzfat, Israel.

Backgrounds: Ramadan fast is a religious custom in Islam. Increased serum uric acid level during this month had been reported in past studies of nongout patients.

Objectives: The objective of this study was to assess the impact of Ramadan fast on patients with gout.

View Article and Find Full Text PDF

Objective: To describe the changes over a 9-year period in the number and rate of diagnostic testing after the introduction of the combined first-trimester screen and subsequent noninvasive prenatal testing.

Methods: The number of prenatal screening and diagnostic tests was recorded over a 9-year period from billing records. Three time intervals were considered: 1) 20 months before a combined first-trimester screen was offered; 2) 72 months after a combined first-trimester screen was offered; and 3) 16 months after noninvasive prenatal testing introduction.

View Article and Find Full Text PDF